As of Oct 22
| +0.04 / +0.72%|
The 4 analysts offering 12-month price forecasts for TG Therapeutics Inc have a median target of 18.50, with a high estimate of 39.00 and a low estimate of 12.00. The median estimate represents a +232.73% increase from the last price of 5.56.
The current consensus among 4 polled investment analysts is to Buy stock in TG Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.